-
1
-
-
2642709177
-
Declining morbidity and mortality, among patients with advanced human immunodeficiency virus infection
-
Palella, F. J. Jr et al. Declining morbidity and mortality, among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338, 853-860 (1998).
-
(1998)
N. Engl. J. Med.
, vol.338
, pp. 853-860
-
-
Palella Jr., F.J.1
-
2
-
-
0033587510
-
Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions
-
Lucas, G. M., Chaisson, R. E. & Moore, R. D. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions. Ann. Intern. Med. 131, 81-87 (1999).
-
(1999)
Ann. Intern. Med.
, vol.131
, pp. 81-87
-
-
Lucas, G.M.1
Chaisson, R.E.2
Moore, R.D.3
-
3
-
-
0033612928
-
Transmission of antiretroviral-drug-resistant HIV-1 variants
-
Yerly, S. et al. Transmission of antiretroviral-drug-resistant HIV-1 variants. Lancet 354, 729-733 (1999).
-
(1999)
Lancet
, vol.354
, pp. 729-733
-
-
Yerly, S.1
-
4
-
-
0033609374
-
Persistence of HIV-1 transcription in peripheral blood mononuclear cells in patients receiving potent antiretroviral therapy
-
Furtado, M. R. et al. Persistence of HIV-1 transcription in peripheral blood mononuclear cells in patients receiving potent antiretroviral therapy. W. Engl. J. Med. 340, 1614-1622 (1999).
-
(1999)
W. Engl. J. Med.
, vol.340
, pp. 1614-1622
-
-
Furtado, M.R.1
-
5
-
-
0033289665
-
Microbicides and barrier methods in HIV prevention
-
Van Damme, L. & Rosenberg, Z. F. Microbicides and barrier methods in HIV prevention. AIDS 13, S85-S92 (1999).
-
(1999)
AIDS
, vol.13
-
-
Van Damme, L.1
Rosenberg, Z.F.2
-
6
-
-
0031976829
-
Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4-independent and gp120 dependent and requires cell surface heparans
-
Mondor, I., Ugolini, S. & Sattentau, Q. J. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4-independent and gp120 dependent and requires cell surface heparans. J. Virol. 72, 3623-3634 (1998).
-
(1998)
J. Virol.
, vol.72
, pp. 3623-3634
-
-
Mondor, I.1
Ugolini, S.2
Sattentau, Q.J.3
-
7
-
-
0033920212
-
Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120
-
Moulard, M. et al. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. J. Virol. 74, 1948-1960 (2000).
-
(2000)
J. Virol.
, vol.74
, pp. 1948-1960
-
-
Moulard, M.1
-
8
-
-
0034598934
-
DC SIGN, a dendritic cell specific HIV-1-binding protein that enhances transinfection of T cells
-
Geijtenbeek, T. B. H. et al. DC SIGN, a dendritic cell specific HIV-1-binding protein that enhances transinfection of T cells. Cell 100, 575-585 (2000).
-
(2000)
Cell
, vol.100
, pp. 575-585
-
-
Geijtenbeek, T.B.H.1
-
9
-
-
0034009465
-
Increased infectivity of HIV type 1 particles bound to cell surface and solid-phase ICAM-1 and VCAM-1 through acquired adhesion molecules LFA-1 and VLA-4
-
Liao, Z., Roos, J. W. & Hildreth, J. E. K. Increased infectivity of HIV type 1 particles bound to cell surface and solid-phase ICAM-1 and VCAM-1 through acquired adhesion molecules LFA-1 and VLA-4. AIDS Res. Hum. Retroviruses 16, 355-366 (2000).
-
(2000)
AIDS Res. Hum. Retroviruses
, vol.16
, pp. 355-366
-
-
Liao, Z.1
Roos, J.W.2
Hildreth, J.E.K.3
-
10
-
-
0032921247
-
Cyanovirin-N binds to gp120 to interfere with CD4 dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120
-
Esser, M. T. et al. Cyanovirin-N binds to gp120 to interfere with CD4 dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120. J. Virol. 73, 4360-4371 (1999).
-
(1999)
J. Virol.
, vol.73
, pp. 4360-4371
-
-
Esser, M.T.1
-
11
-
-
0029731557
-
SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids
-
Delezay, O., Hammache, D., Fantini, J. & Yahi, N. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids. Biochemistry 35, 15663-15671 (1996).
-
(1996)
Biochemistry
, vol.35
, pp. 15663-15671
-
-
Delezay, O.1
Hammache, D.2
Fantini, J.3
Yahi, N.4
-
12
-
-
0032543307
-
Structure of an HIV gp120 envelope glycoprotein complex with the CD4 receptor and a neutralizing human antibody
-
Kwong, P. D. et al. Structure of an HIV gp120 envelope glycoprotein complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648-659 (1998).
-
(1998)
Nature
, vol.393
, pp. 648-659
-
-
Kwong, P.D.1
-
13
-
-
17544388251
-
The bis-azo compound FP 21399 inhibits HIV-1 replication by preventing viral entry
-
Zhang, J. L. et al. The bis-azo compound FP 21399 inhibits HIV-1 replication by preventing viral entry. Virology 244, 530-541 (1998).
-
(1998)
Virology
, vol.244
, pp. 530-541
-
-
Zhang, J.L.1
-
14
-
-
0025987015
-
Soluble CD4 and dextran sulphate mediate release of gp120 from HIV-1: Implications for clinical trials
-
Bugelski, P. J., Ellens, H., Hart, T. K. & Kirsh, R. L. Soluble CD4 and dextran sulphate mediate release of gp120 from HIV-1: Implications for clinical trials. J. Acq. Immun. Def. Synd. 4, 923-924 (1991).
-
(1991)
J. Acq. Immun. Def. Synd.
, vol.4
, pp. 923-924
-
-
Bugelski, P.J.1
Ellens, H.2
Hart, T.K.3
Kirsh, R.L.4
-
15
-
-
0033589780
-
Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4
-
Cabrera, C. et al. Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4. AIDS Res. Hum. Retroviruses 15, 1535-1543 (1999).
-
(1999)
AIDS Res. Hum. Retroviruses
, vol.15
, pp. 1535-1543
-
-
Cabrera, C.1
-
16
-
-
0033914939
-
Single-dose safety, pharmacology and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults
-
Jacobson, J. M. et al. Single-dose safety, pharmacology and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults. J. Infect. Dis. 182, 326-329 (2000).
-
(2000)
J. Infect. Dis.
, vol.182
, pp. 326-329
-
-
Jacobson, J.M.1
-
17
-
-
0033587488
-
Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic
-
Zhang, W. et al. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic. Biochemistry 38, 9405-9416 (1999).
-
(1999)
Biochemistry
, vol.38
, pp. 9405-9416
-
-
Zhang, W.1
-
18
-
-
13044292627
-
Rational engineering of a miniprotein that reproduces the core of the.CD4 site interacting with HIV-1 envelope glycoprotein
-
Vita, C. et al. Rational engineering of a miniprotein that reproduces the core of the.CD4 site interacting with HIV-1 envelope glycoprotein. Prac. Natl Acad. Sci. USA 96, 13091-13096 (1999).
-
(1999)
Prac. Natl Acad. Sci. USA
, vol.96
, pp. 13091-13096
-
-
Vita, C.1
-
19
-
-
0030788879
-
A humanized form of a CD4-specific monoclonal antibody exhibits decreased antigenicity and prolonged plasma half-life in rhesus monkeys while retaining its unique biological and antiviral properties
-
Reimann, K. A. et al. A humanized form of a CD4-specific monoclonal antibody exhibits decreased antigenicity and prolonged plasma half-life in rhesus monkeys while retaining its unique biological and antiviral properties. AIDS Res. Hum. Retroviruses 13, 933-943 (1997).
-
(1997)
AIDS Res. Hum. Retroviruses
, vol.13
, pp. 933-943
-
-
Reimann, K.A.1
-
20
-
-
0031298109
-
HIV entry and tropism: The chemokine receptor connection
-
Berger, E. A. HIV entry and tropism: the chemokine receptor connection. AIDS 11, S3-S16 (1997).
-
(1997)
AIDS
, vol.11
-
-
Berger, E.A.1
-
21
-
-
17544384752
-
Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5Δ 32
-
Michael, N. L. et al. Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5Δ 32. J. Virol. 72, 6040-6047 (1998).
-
(1998)
J. Virol.
, vol.72
, pp. 6040-6047
-
-
Michael, N.L.1
-
22
-
-
0033008471
-
Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1?
-
Zhang, Y.-J. & Moore, J. P. Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1? J. Virol. 73, 3443-3448 (1999).
-
(1999)
J. Virol.
, vol.73
, pp. 3443-3448
-
-
Zhang, Y.-J.1
Moore, J.P.2
-
23
-
-
0032728566
-
Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo
-
Glushakova, S. et al. Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo. J. Clin. Invest. 104, R7-R11 (1999).
-
(1999)
J. Clin. Invest.
, vol.104
-
-
Glushakova, S.1
-
24
-
-
0042376485
-
A new classification for HIV-1
-
Berger, E. A. et al. A new classification for HIV-1. Nature 391, 240 (1998).
-
(1998)
Nature
, vol.391
, pp. 240
-
-
Berger, E.A.1
-
25
-
-
0033986873
-
Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: Highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo
-
Veazey, R. S. et al. Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo. J. Virol. 74, 57-64 (2000).
-
(2000)
J. Virol.
, vol.74
, pp. 57-64
-
-
Veazey, R.S.1
-
27
-
-
0001633495
-
Genetic restriction of HIV-1 infection and progression to AIDS by a deletion of the CKR5 structural allele
-
Dean, M. et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion of the CKR5 structural allele. Science 273, 1856-1862 (1996).
-
(1996)
Science
, vol.273
, pp. 1856-1862
-
-
Dean, M.1
-
28
-
-
0030987288
-
CCR5 levels and expression pattern correlate with infectability by macrophage tropic HIV-1, in vitro
-
Wu, L. et al. CCR5 levels and expression pattern correlate with infectability by macrophage tropic HIV-1, in vitro. J. Exp. Med. 185, 1681-1691 (1997).
-
(1997)
J. Exp. Med.
, vol.185
, pp. 1681-1691
-
-
Wu, L.1
-
29
-
-
0032507962
-
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
-
Zou, Y. R., Kottmann, A. H., Kuroda, M., Taniuchi, I. & Littman, D. R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595-599 (1998).
-
(1998)
Nature
, vol.393
, pp. 595-599
-
-
Zou, Y.R.1
Kottmann, A.H.2
Kuroda, M.3
Taniuchi, I.4
Littman, D.R.5
-
30
-
-
0029976181
-
Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry
-
Datema, R. et al. Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry. Antimicrob. Agents Chemother. 40, 750-754 (1996).
-
(1996)
Antimicrob. Agents Chemother.
, vol.40
, pp. 750-754
-
-
Datema, R.1
-
31
-
-
0029417004
-
- T cells
-
- T cells. Science 270, 1811-1815 (1995).
-
(1995)
Science
, vol.270
, pp. 1811-1815
-
-
Cocchi, F.1
-
32
-
-
0029775576
-
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
-
Bleul, C. C. et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829-833 (1996).
-
(1996)
Nature
, vol.382
, pp. 829-833
-
-
Bleul, C.C.1
-
33
-
-
16044370087
-
The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line adapted HIV-1
-
Obertin, E. et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line adapted HIV-1. Nature 382, 833-835 (1996).
-
(1996)
Nature
, vol.382
, pp. 833-835
-
-
Obertin, E.1
-
34
-
-
0030951442
-
Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist
-
Simmons, G. et al. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 276, 276-279 (1997).
-
(1997)
Science
, vol.276
, pp. 276-279
-
-
Simmons, G.1
-
35
-
-
0032568336
-
Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides
-
Heveker, N. et al. Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides. Curr. Biol. 8, 369-376 (1998).
-
(1998)
Curr. Biol.
, vol.8
, pp. 369-376
-
-
Heveker, N.1
-
36
-
-
0030745286
-
HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication
-
Amara, A. et al. HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186, 139-146 (1997).
-
(1997)
J. Exp. Med.
, vol.186
, pp. 139-146
-
-
Amara, A.1
-
37
-
-
0032550337
-
Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: A novel inhibitory mechanism of HIV infectivity
-
Mack, M. et al. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: A novel inhibitory mechanism of HIV infectivity. J. Exp. Med. 187, 1215-1224 (1998).
-
(1998)
J. Exp. Med.
, vol.187
, pp. 1215-1224
-
-
Mack, M.1
-
38
-
-
0031963975
-
Genetic subtype independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines
-
Trkola, A. et al. Genetic subtype independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines. J. Virol. 72, 396-404 (1998).
-
(1998)
J. Virol.
, vol.72
, pp. 396-404
-
-
Trkola, A.1
-
39
-
-
13144262826
-
+ T cells: Role of signal transduction
-
+ T cells: Role of signal transduction. Proc. NatlAcad. Sci. USA 95, 11880-11885 (1998).
-
(1998)
Proc. NatlAcad. Sci. USA
, vol.95
, pp. 11880-11885
-
-
Kinter, A.1
-
40
-
-
0345003718
-
Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication?
-
Marechal, V., Arenzana-Seisdedos, F., Heard, J.-M. & Schwartz, O. Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication? J. Virol. 73, 3608-3615 (1999).
-
(1999)
J. Virol.
, vol.73
, pp. 3608-3615
-
-
Marechal, V.1
Arenzana-Seisdedos, F.2
Heard, J.-M.3
Schwartz, O.4
-
41
-
-
0032768967
-
The CC chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosoaminoglycans, and also activates a signal transduction pathway that enhances viral infectivity
-
Trkola, A. et al. The CC chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosoaminoglycans, and also activates a signal transduction pathway that enhances viral infectivity. J. Virol. 73, 6370-6379 (1999).
-
(1999)
J. Virol.
, vol.73
, pp. 6370-6379
-
-
Trkola, A.1
-
42
-
-
0032924183
-
Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants
-
Mosier, D. E. et al. Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants. J. Virol. 73, 3544-3550 (1999).
-
(1999)
J. Virol.
, vol.73
, pp. 3544-3550
-
-
Mosier, D.E.1
-
43
-
-
16144365390
-
CD4-independent infection by HIV-2 is mediated by fusin/CXCR4
-
Endres, M. J. et al. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87, 745-756 (1996).
-
(1996)
Cell
, vol.87
, pp. 745-756
-
-
Endres, M.J.1
-
44
-
-
0032902710
-
Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC chemokine activity by monoclonal antibodies to CCR5
-
Olson, W. C. et al. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC chemokine activity by monoclonal antibodies to CCR5. J. Virol. 73, 4145-4155 (1999).
-
(1999)
J. Virol.
, vol.73
, pp. 4145-4155
-
-
Olson, W.C.1
-
45
-
-
0030830661
-
Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4
-
Schols, D. et al. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J. Exp. Med. 186, 1383-1388 (1997).
-
(1997)
J. Exp. Med.
, vol.186
, pp. 1383-1388
-
-
Schols, D.1
-
46
-
-
0030780377
-
A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection
-
Murakami, T. et al. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. J. Exp. Med. 186, 1389-1393 (1997).
-
(1997)
J. Exp. Med.
, vol.186
, pp. 1389-1393
-
-
Murakami, T.1
-
47
-
-
0030773515
-
A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor
-
Doranz, B. J. et al. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J. Exp. Med. 186, 1395-1400 (1997).
-
(1997)
J. Exp. Med.
, vol.186
, pp. 1395-1400
-
-
Doranz, B.J.1
-
48
-
-
0031891516
-
AMD3100, a small molecule inhibitor of HPV-1 entry via the CXCR4 co-receptor
-
Donzella, G. A. et al. AMD3100, a small molecule inhibitor of HPV-1 entry via the CXCR4 co-receptor. Nature Med. 4, 72-77 (1998).
-
(1998)
Nature Med.
, vol.4
, pp. 72-77
-
-
Donzella, G.A.1
-
49
-
-
0032954383
-
T134, a small-molecule CXCR4 inhibitor, has no cross drug resistance with AMD3100, a CXCR4 antagonist with a different structure
-
Arakaki, R. et al. T134, a small-molecule CXCR4 inhibitor, has no cross drug resistance with AMD3100, a CXCR4 antagonist with a different structure. J. Virol. 73, 1719-1723 (1999).
-
(1999)
J. Virol.
, vol.73
, pp. 1719-1723
-
-
Arakaki, R.1
-
50
-
-
0031596253
-
T-tropic human immunodeficiency virus type 1 (HIV-1) derived V3 loop peptides directly bind to CXCR-4 and inhibit T-tropic HIV-1 infection
-
Sakaida, H. et al. T-tropic human immunodeficiency virus type 1 (HIV-1) derived V3 loop peptides directly bind to CXCR-4 and inhibit T-tropic HIV-1 infection. J. Virol. 72, 9763-9770 (1998).
-
(1998)
J. Virol.
, vol.72
, pp. 9763-9770
-
-
Sakaida, H.1
-
51
-
-
13044256383
-
A small molecule nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
-
Baba, M. et al. A small molecule nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc. Natl Acad. Sci. USA 96, 5698-5703 (1999).
-
(1999)
Proc. Natl Acad. Sci. USA
, vol.96
, pp. 5698-5703
-
-
Baba, M.1
-
52
-
-
14444282418
-
Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: A candidate for chemotherapeutic and microbicidal application
-
Howard, O. M. Z. et al. Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: A candidate for chemotherapeutic and microbicidal application. J. Med. Chem. 41, 2184-2193 (1998).
-
(1998)
J. Med. Chem.
, vol.41
, pp. 2184-2193
-
-
Howard, O.M.Z.1
-
53
-
-
0026465468
-
A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition
-
Wild, C., Oas, T., McDanal, C., Bolognesi, D. & Matthews, T. A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition. Proc. Natl Acad. Sci. USA 89, 10537-10541 (1992).
-
(1992)
Proc. Natl Acad. Sci. USA
, vol.89
, pp. 10537-10541
-
-
Wild, C.1
Oas, T.2
McDanal, C.3
Bolognesi, D.4
Matthews, T.5
-
54
-
-
0027179560
-
HIV-1 inhibition by a peptide
-
Jiang, S., Lin, K., Strick, N. & Neurath, A. R. HIV-1 inhibition by a peptide. Nature 365, 113 (1993).
-
(1993)
Nature
, vol.365
, pp. 113
-
-
Jiang, S.1
Lin, K.2
Strick, N.3
Neurath, A.R.4
-
55
-
-
0031962175
-
Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors
-
Jones, P. L., Korte, T. & Blumenthal, R. Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors. J. Biol. Chem. 273, 404-409 (1998).
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 404-409
-
-
Jones, P.L.1
Korte, T.2
Blumenthal, R.3
-
56
-
-
0031729823
-
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
-
Kilby, J. M. et al. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nature Med. 4, 1302-1307 (1998).
-
(1998)
Nature Med.
, vol.4
, pp. 1302-1307
-
-
Kilby, J.M.1
-
57
-
-
0032876381
-
Selection of gp41-mediated HIV-1 cell entry inhibition from biased combinational libraries of non-natural binding elements
-
Ferrer, M. et al. Selection of gp41-mediated HIV-1 cell entry inhibition from biased combinational libraries of non-natural binding elements. Nature Struct. Biol. 6, 953-959 (1999).
-
(1999)
Nature Struct. Biol.
, vol.6
, pp. 953-959
-
-
Ferrer, M.1
-
58
-
-
0033214895
-
Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled coil pocket
-
Eckert, D. M., Malashkevich, V. N., Hong, L. H., Carr, P. A. & Kim, P. S. Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled coil pocket. Cell 99, 103-115 (1999).
-
(1999)
Cell
, vol.99
, pp. 103-115
-
-
Eckert, D.M.1
Malashkevich, V.N.2
Hong, L.H.3
Carr, P.A.4
Kim, P.S.5
-
59
-
-
0033981739
-
Sensitivity to a nonpeptidic compound (RPR103611) blocking human immunodeficiency virus type 1 env-mediated fusion depends on the sequence and accessibility of the gp41 loop region
-
Labrosse, B., Treboute, C. & Alizon, M. Sensitivity to a nonpeptidic compound (RPR103611) blocking human immunodeficiency virus type 1 env-mediated fusion depends on the sequence and accessibility of the gp41 loop region. J. Virol. 74, 2142-2150 (2000).
-
(2000)
J. Virol.
, vol.74
, pp. 2142-2150
-
-
Labrosse, B.1
Treboute, C.2
Alizon, M.3
-
60
-
-
0025281325
-
The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope
-
Wilson, C. et al. The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope. J. Virol. 64, 3240-3248 (1990).
-
(1990)
J. Virol.
, vol.64
, pp. 3240-3248
-
-
Wilson, C.1
-
61
-
-
0032560463
-
A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV 1 envelope glycoprotein-mediated cell fusion
-
Pritsker, M., Jones, P., Blumenthal, R. & Shai, Y. A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV 1 envelope glycoprotein-mediated cell fusion. Proc. Natl Acad. Sci. USA 95, 7287-7292 (1998).
-
(1998)
Proc. Natl Acad. Sci. USA
, vol.95
, pp. 7287-7292
-
-
Pritsker, M.1
Jones, P.2
Blumenthal, R.3
Shai, Y.4
-
62
-
-
0031883832
-
Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides
-
Rimsky, L. T., Shugars, D. C. & Matthews, T. J. Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides. J. Virol. 72, 986-993 (1998).
-
(1998)
J. Virol.
, vol.72
, pp. 986-993
-
-
Rimsky, L.T.1
Shugars, D.C.2
Matthews, T.J.3
-
63
-
-
0003973947
-
The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication
-
De Vreese, K. et al. The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication. J. Virol. 70, 689-696 (1996).
-
(1996)
J. Virol.
, vol.70
, pp. 689-696
-
-
De Vreese, K.1
-
64
-
-
0031968673
-
T-cell-line tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1α contains mutations in the envelope gp120 but does not show a switch in coreceptor use
-
Schols, D., Esté, J. A., Cabrera, C. & De Clercq, E. T-cell-line tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1α contains mutations in the envelope gp120 but does not show a switch in coreceptor use. J. Virol. 72, 4032-4037 (1998).
-
(1998)
J. Virol.
, vol.72
, pp. 4032-4037
-
-
Schols, D.1
Esté, J.A.2
Cabrera, C.3
De Clercq, E.4
-
65
-
-
0033059948
-
Shift of clinical human immunodeficiency virus type 1 isolates from X4 to X5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4
-
Esté, J. A. et al. Shift of clinical human immunodeficiency virus type 1 isolates from X4 to X5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4. J. Virol. 73, 5577-5585 (1999).
-
(1999)
J. Virol.
, vol.73
, pp. 5577-5585
-
-
Esté, J.A.1
-
66
-
-
0033937219
-
Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha
-
Maeda, Y., Foda, M., Matsushita, S. & Harada, S. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha. J. Virol. 74, 1787-1793 (2000).
-
(2000)
J. Virol.
, vol.74
, pp. 1787-1793
-
-
Maeda, Y.1
Foda, M.2
Matsushita, S.3
Harada, S.4
-
67
-
-
0027940713
-
Specific incorporation of cyclophilin a into HIV-1 virions
-
Franke, E. K., Yuan, H. E. H. & Luban, J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372, 359-362 (1994).
-
(1994)
Nature
, vol.372
, pp. 359-362
-
-
Franke, E.K.1
Yuan, H.E.H.2
Luban, J.3
-
68
-
-
0027971782
-
Functional association of cyclophilin A with HIV-1 virions
-
Thali, M. et al. Functional association of cyclophilin A with HIV-1 virions. Nature 372, 363-365 (1994).
-
(1994)
Nature
, vol.372
, pp. 363-365
-
-
Thali, M.1
-
69
-
-
0029895725
-
Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that gag encodes functional target of cyclophilin A
-
Braaten, D. et al. Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that gag encodes functional target of cyclophilin A. J. Virol. 70, 5170-5176 (1996).
-
(1996)
J. Virol.
, vol.70
, pp. 5170-5176
-
-
Braaten, D.1
-
70
-
-
0033102481
-
Antiretroviral therapy: 'The state of the art'
-
Montaner, J. S., Montessori, V. Harrigan, R., O'Shaughnessy, M. & Hogg, R. Antiretroviral therapy: 'the state of the art'. Biomed. Phamacother. 53, 63-72 (1999).
-
(1999)
Biomed. Phamacother.
, vol.53
, pp. 63-72
-
-
Montaner, J.S.1
Montessori, V.2
Harrigan, R.3
O'Shaughnessy, M.4
Hogg, R.5
-
71
-
-
0032993043
-
The P236L delavirdine-resistant human immunodeficiency virus type 1 mutant is replication defective and demonstrates alterations in both RNA 5′-end- And DNA 3′-end-directed RNase H activities
-
Gerondelis, P. et al. The P236L delavirdine-resistant human immunodeficiency virus type 1 mutant is replication defective and demonstrates alterations in both RNA 5′-end-and DNA 3′-end-directed RNase H activities. J. Virol. 73, 5803-5813 (1999).
-
(1999)
J. Virol.
, vol.73
, pp. 5803-5813
-
-
Gerondelis, P.1
-
72
-
-
0029585377
-
First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses
-
Darlix, J. L., Lapadat-Tapolsky, M., de Rocquigny, H. & Roques, B. P. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J. Mol. Biol. 254, 523-537 (1995).
-
(1995)
J. Mol. Biol.
, vol.254
, pp. 523-537
-
-
Darlix, J.L.1
Lapadat-Tapolsky, M.2
De Rocquigny, H.3
Roques, B.P.4
-
73
-
-
0030019808
-
The in vitro ejection of zinc from human immunodeficiency virus (HIV) type 1 nucleocapsid protein by disulfide benzamides with cellular anti- HIV activity
-
Tummino, P. J. et al. The in vitro ejection of zinc from human immunodeficiency virus (HIV) type 1 nucleocapsid protein by disulfide benzamides with cellular anti-HIV activity. Proc. Natl Acad. Sci. USA 93, 969-973 (1996).
-
(1996)
Proc. Natl Acad. Sci. USA
, vol.93
, pp. 969-973
-
-
Tummino, P.J.1
-
74
-
-
0028875771
-
Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS
-
Rice, W. G. et al. Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science 270, 1194-1197 (1995).
-
(1995)
Science
, vol.270
, pp. 1194-1197
-
-
Rice, W.G.1
-
75
-
-
0033552881
-
Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers
-
Turpin, J. A. et al. Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers. J. Med. Chem. 42, 67-86 (1999).
-
(1999)
J. Med. Chem.
, vol.42
, pp. 67-86
-
-
Turpin, J.A.1
-
76
-
-
0031956156
-
Role of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication
-
Tanchou, V. et al. Role of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication. J. Virol. 72, 4442-4447 (1998).
-
(1998)
J. Virol.
, vol.72
, pp. 4442-4447
-
-
Tanchou, V.1
-
77
-
-
0032776165
-
Coupled integration of human immunodeficiency virus type 1 cDNA ends by purified integrase in vitro: Stimulation by the viral nucleocapsid protein
-
Carteau, S., Gorelick, R. J. & Bushman, F. D. Coupled integration of human immunodeficiency virus type 1 cDNA ends by purified integrase in vitro: stimulation by the viral nucleocapsid protein. J. Virol. 73, 6670-6679 (1999).
-
(1999)
J. Virol.
, vol.73
, pp. 6670-6679
-
-
Carteau, S.1
Gorelick, R.J.2
Bushman, F.D.3
-
78
-
-
0344671562
-
Multiple effects of an anti-human immunodeficiency virus nucleocapsid inhibitor on virus morphology and replication
-
Berthoux, L., Pechoux, C. & Darlix, J. L. Multiple effects of an anti-human immunodeficiency virus nucleocapsid inhibitor on virus morphology and replication. J. Virol. 73, 10000-10009 (1999).
-
(1999)
J. Virol.
, vol.73
, pp. 10000-10009
-
-
Berthoux, L.1
Pechoux, C.2
Darlix, J.L.3
-
79
-
-
0025342694
-
HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
-
Zack, J. A. et al. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61, 213-222 (1990).
-
(1990)
Cell
, vol.61
, pp. 213-222
-
-
Zack, J.A.1
-
80
-
-
0025238945
-
HIV-1 replication is controlled at the level of T cell activation and proviral integration
-
Stevenson, M., Stanwick, T. L. Dempsey, M. P. & Lamonica, C. A. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9, 1551-1560 (1990).
-
(1990)
EMBO J.
, vol.9
, pp. 1551-1560
-
-
Stevenson, M.1
Stanwick, T.L.2
Dempsey, M.P.3
Lamonica, C.A.4
-
81
-
-
0032567042
-
Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells
-
Kinoshita, S., Chen, B. K., Kaneshima, H. & Nolan, G. P. Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells. Cell 95, 595-604 (1998).
-
(1998)
Cell
, vol.95
, pp. 595-604
-
-
Kinoshita, S.1
Chen, B.K.2
Kaneshima, H.3
Nolan, G.P.4
-
82
-
-
0025871394
-
Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporine A
-
Flanagan, W. M., Corthesy, B., Bram, R. J. & Crabtree, G. R. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporine A. Nature 352, 803-807 (1991).
-
(1991)
Nature
, vol.352
, pp. 803-807
-
-
Flanagan, W.M.1
Corthesy, B.2
Bram, R.J.3
Crabtree, G.R.4
-
83
-
-
0034646513
-
HIV-1 genome nuclear import is mediated by a central DNa flap
-
Zennou, V. et al. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101, 173-185 (2000).
-
(2000)
Cell
, vol.101
, pp. 173-185
-
-
Zennou, V.1
-
84
-
-
0027965903
-
HIV-1 reverse transcription. A termination step at the center of the genome
-
Charneau, P. et al. HIV-1 reverse transcription. A termination step at the center of the genome. J. Mol. Biol. 241, 651-662 (1994).
-
(1994)
J. Mol. Biol.
, vol.241
, pp. 651-662
-
-
Charneau, P.1
-
85
-
-
0027199982
-
Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection
-
Bukrinsky, M. I. et al. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl Acad. Sci. USA 90, 6125-6129 (1993).
-
(1993)
Proc. Natl Acad. Sci. USA
, vol.90
, pp. 6125-6129
-
-
Bukrinsky, M.I.1
-
86
-
-
0031603418
-
Retroviral cDNA integration: Mechanism, applications and inhibition
-
Hansen, M. S., Carteau, S., Hoffmann, C., Li, L. & Bushman, F. Retroviral cDNA integration: mechanism, applications and inhibition. Genet. Eng. 20, 41-61 (1998).
-
(1998)
Genet. Eng.
, vol.20
, pp. 41-61
-
-
Hansen, M.S.1
Carteau, S.2
Hoffmann, C.3
Li, L.4
Bushman, F.5
-
87
-
-
0028924020
-
Human immunodeficiency virus type 1 integrase: Effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells
-
Wiskerchen, M. & Muesing, M. A. Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. J. Virol. 69, 376-386 (1995).
-
(1995)
J. Virol.
, vol.69
, pp. 376-386
-
-
Wiskerchen, M.1
Muesing, M.A.2
-
88
-
-
0031060473
-
Equivalent inhibition of half-site and full-site retroviral strand transfer reactions by structurally diverse compounds
-
Hazuda, D. et al. Equivalent inhibition of half-site and full-site retroviral strand transfer reactions by structurally diverse compounds. J. Virol. 71, 807-811 (1997).
-
(1997)
J. Virol.
, vol.71
, pp. 807-811
-
-
Hazuda, D.1
-
89
-
-
14444276046
-
Salicylhydrazine-containing inhibitors of HIV-1 integrase: Implication for a selective chelation in the integrase active site
-
Neamati, N. et al. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site. J. Med. Chem. 41, 3202-3209 (1998).
-
(1998)
J. Med. Chem.
, vol.41
, pp. 3202-3209
-
-
Neamati, N.1
-
90
-
-
0034723439
-
Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells
-
Hazuda, D. J. et al. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science 287, 646-650 (2000).
-
(2000)
Science
, vol.287
, pp. 646-650
-
-
Hazuda, D.J.1
-
91
-
-
0030987672
-
HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
-
Gallay, P., Hope,T., Chin, D. & Trono, D. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl Acad. Sci. USA 94, 9825-9830 (1997).
-
(1997)
Proc. Natl Acad. Sci. USA
, vol.94
, pp. 9825-9830
-
-
Gallay, P.1
Hope, T.2
Chin, D.3
Trono, D.4
-
92
-
-
0033526522
-
Nuclear localization of human immunodeficiency virus type 1 integrase expressed as a fusion protein with green fluorescent protein
-
Pluymers, W., Cherepanov, P., Schols, D., De Clercq, E. & Debyser, Z. Nuclear localization of human immunodeficiency virus type 1 integrase expressed as a fusion protein with green fluorescent protein. Virology 258, 327-332 (1999).
-
(1999)
Virology
, vol.258
, pp. 327-332
-
-
Pluymers, W.1
Cherepanov, P.2
Schols, D.3
De Clercq, E.4
Debyser, Z.5
-
93
-
-
0347120545
-
HIV nuclear import: What's all the flap?
-
Stevenson, M. HIV nuclear import: What's all the flap? Nature Med. 6, 9-10 (2000).
-
(2000)
Nature Med.
, vol.6
, pp. 9-10
-
-
Stevenson, M.1
-
94
-
-
0034717161
-
Probing contacts between the ribonuclease H domain of HIV-1 reverse transcriptase and nucleic acid by site specific photocrosslinking
-
Rausch, J. W., Sathyanaryana, B. K., Bona, M. K. & Le Grice, S. F. Probing contacts between the ribonuclease H domain of HIV-1 reverse transcriptase and nucleic acid by site specific photocrosslinking. J. Biol. Chem. 3, 16015-16022 (2000).
-
(2000)
J. Biol. Chem.
, vol.3
, pp. 16015-16022
-
-
Rausch, J.W.1
Sathyanaryana, B.K.2
Bona, M.K.3
Le Grice, S.F.4
-
95
-
-
0031788565
-
Evidence for a newly discovered cellular anti-HIV phenotype
-
Simon, J. H., Gaddis, N. C., Fouchier, R. A. & Malim, M. H. Evidence for a newly discovered cellular anti-HIV phenotype. Nature Med. 4, 1397-1400 (1998).
-
(1998)
Nature Med.
, vol.4
, pp. 1397-1400
-
-
Simon, J.H.1
Gaddis, N.C.2
Fouchier, R.A.3
Malim, M.H.4
-
96
-
-
0031797865
-
An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein
-
Madani, N. & Kabat, D. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J. Virol. 72, 10251-10255 (1998).
-
(1998)
J. Virol.
, vol.72
, pp. 10251-10255
-
-
Madani, N.1
Kabat, D.2
-
97
-
-
0031927202
-
Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100
-
Labrosse, B. et al. Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100. J. Virol. 72, 6381-6388 (1998).
-
(1998)
J. Virol.
, vol.72
, pp. 6381-6388
-
-
Labrosse, B.1
-
98
-
-
0032815929
-
Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection
-
Murakami, T. et al. Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection. J. Virol. 73, 7489-7496 (1999).
-
(1999)
J. Virol.
, vol.73
, pp. 7489-7496
-
-
Murakami, T.1
-
99
-
-
0034625144
-
A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5
-
Dragic, T. et al. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc. Natl Acad. Sci. USA 97, 5639-5644 (2000).
-
(2000)
Proc. Natl Acad. Sci. USA
, vol.97
, pp. 5639-5644
-
-
Dragic, T.1
-
100
-
-
0033521097
-
Inhibition of G-protein coupled receptor functions by disruption of transmembrane domain interactions
-
Tarasova, N. I., Rice, W. G. & Michejda, C. J. Inhibition of G-protein coupled receptor functions by disruption of transmembrane domain interactions. J. Biol. Chem. 274, 34911-34915 (1999).
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 34911-34915
-
-
Tarasova, N.I.1
Rice, W.G.2
Michejda, C.J.3
-
101
-
-
0030962291
-
Atomic structure of the ectodomain from gp41
-
Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J. & Wiley, D. C. Atomic structure of the ectodomain from gp41. Nature 387, 426-430 (1997).
-
(1997)
Nature
, vol.387
, pp. 426-430
-
-
Weissenhorn, W.1
Dessen, A.2
Harrison, S.C.3
Skehel, J.J.4
Wiley, D.C.5
-
102
-
-
0030970693
-
Core structure of gp41 from the HIV envelope glycoprotein
-
Chan, D. C., Fass, D., Berger, J. M. & Kim, P. S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89, 263-273 (1997).
-
(1997)
Cell
, vol.89
, pp. 263-273
-
-
Chan, D.C.1
Fass, D.2
Berger, J.M.3
Kim, P.S.4
-
103
-
-
0032541424
-
Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41
-
Caffrey, M. et al. Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41. EMBO J. 17, 4572-4584 (1998).
-
(1998)
EMBO J.
, vol.17
, pp. 4572-4584
-
-
Caffrey, M.1
-
104
-
-
0033525590
-
Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry
-
Farzan, M. et al. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96, 667-676 (1999).
-
(1999)
Cell
, vol.96
, pp. 667-676
-
-
Farzan, M.1
-
105
-
-
0033920212
-
Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120
-
Moulard, M. et al. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. J. Virol. 74, 1948-1960 (2000).
-
(2000)
J. Virol.
, vol.74
, pp. 1948-1960
-
-
Moulard, M.1
|